Skip to content

  • Home
  • News
  • Twitter
  • Facebook
  • YouTube
  • LinkedIn
  • Dribbble
  • Instagram
Cogmain Healthcare

Cogmain Healthcare

HEALTHCARE & PHARMACEUTICALS MARKET RESEARCH

  • Home
  • News

Tag: allergy

  • FIRST DEATH FOLLOWING COVID-19 VACCINATION

    FIRST DEATH FOLLOWING COVID-19 VACCINATION

    News, Pharma, SARS-Cov2

    ·

    By

    Swikriti Chauhan

    –

    June 18, 2021

    A 68 year old man has died after being fully vaccinated with the covishield vaccine in the month of March due to anaphylaxis, which is considered as a severe allergic…

Follow Us

  • Twitter
  • YouTube
  • Facebook
  • Instagram
  • LinkedIn
  • Dribbble

Category Name

  • Bedaquiline Role in Treating Tuberculosis having a hefty $1.38 billion dollar market

    Bedaquiline Role in Treating Tuberculosis having a hefty $1.38 billion dollar market

  • Adalimumab’s competition and immense market Growth Potential of 5.1%

    Adalimumab’s competition and immense market Growth Potential of 5.1%

  • Semaglutide’s massive influence on the Diabetes Pharmaceutical Market and 6 competitors

    Semaglutide’s massive influence on the Diabetes Pharmaceutical Market and 6 competitors

Recent Posts

  • Bedaquiline Role in Treating Tuberculosis having a hefty $1.38 billion dollar market
    Immune System, Tuberculosis

    Bedaquiline Role in Treating Tuberculosis having a hefty $1.38 billion dollar market

  • Adalimumab’s competition and immense market Growth Potential of 5.1%
    Auto-immune diseases, Healthcare, News, Pharma

    Adalimumab’s competition and immense market Growth Potential of 5.1%

  • Semaglutide’s massive influence on the Diabetes Pharmaceutical Market and 6 competitors
    Pharma, Diabetes, Healthcare, News

    Semaglutide’s massive influence on the Diabetes Pharmaceutical Market and 6 competitors

  • FDA approved Leqembi to have $12.9 billion sales
    Alzheimers, News, Pharma, Research

    FDA approved Leqembi to have $12.9 billion sales

  • Assistive Technology Market; a $82B Growth Story
    Healthcare, Elderly Health, News

    Assistive Technology Market; a $82B Growth Story

Tags

Autoimmunity cancer cancer research cancer therapy CDSCO covid-19 covid in children Diabetes drug Elderly Health FDA healthcare immune response Kerala mutations Nipah virus pandemic PCOS pharma Pharmaceutical market pharma sector protein-based vaccines sars-cov-2 therapy third wave Treatment vaccine variants WHO zydus cadila

About Us

A block theme is a WordPress theme with templates entirely composed of blocks. Therefore, in addition to the content of different post types (pages, posts, etc.), the block editor can also be used to edit all areas of the website.

  • Twitter
  • Facebook
  • Instagram
  • Dribbble
  • LinkedIn
  • YouTube

Cancer

  • Bedaquiline Role in Treating Tuberculosis having a hefty $1.38 billion dollar market

    Bedaquiline Role in Treating Tuberculosis having a hefty $1.38 billion dollar market

  • Adalimumab’s competition and immense market Growth Potential of 5.1%

    Adalimumab’s competition and immense market Growth Potential of 5.1%

Healthcare

  • Bedaquiline Role in Treating Tuberculosis having a hefty $1.38 billion dollar market

    Bedaquiline Role in Treating Tuberculosis having a hefty $1.38 billion dollar market

  • Adalimumab’s competition and immense market Growth Potential of 5.1%

    Adalimumab’s competition and immense market Growth Potential of 5.1%

  • Semaglutide’s massive influence on the Diabetes Pharmaceutical Market and 6 competitors

    Semaglutide’s massive influence on the Diabetes Pharmaceutical Market and 6 competitors

Cogmain HEALTHCARE
MARKET RESEARCH

  • Healthcare
  • News
  • Contact Us
  • Home
  • News

WordPress Theme by WPEnjoy